BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 19486034)

  • 1. A prostaglandin D2 receptor antagonist modifies experimental asthma in sheep.
    Shichijo M; Arimura A; Hirano Y; Yasui K; Suzuki N; Deguchi M; Abraham WM
    Clin Exp Allergy; 2009 Sep; 39(9):1404-14. PubMed ID: 19486034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation.
    Uller L; Mathiesen JM; Alenmyr L; Korsgren M; Ulven T; Högberg T; Andersson G; Persson CG; Kostenis E
    Respir Res; 2007 Feb; 8(1):16. PubMed ID: 17328802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of prostaglandin D2 via prostanoid DP receptor to nasal hyperresponsiveness in guinea pigs repeatedly exposed to antigen.
    Yasui K; Asanuma F; Hirano Y; Shichijo M; Deguchi M; Arimura A
    Eur J Pharmacol; 2008 Jan; 578(2-3):286-91. PubMed ID: 17927976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells.
    Hirano Y; Shichijo M; Deguchi M; Nagira M; Suzuki N; Nishitani Y; Hattori M; Arimura A
    Eur J Pharmacol; 2007 Mar; 560(1):81-8. PubMed ID: 17307163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation.
    Stebbins KJ; Broadhead AR; Correa LD; Scott JM; Truong YP; Stearns BA; Hutchinson JH; Prasit P; Evans JF; Lorrain DS
    Eur J Pharmacol; 2010 Jul; 638(1-3):142-9. PubMed ID: 20447387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases.
    Schuligoi R; Sturm E; Luschnig P; Konya V; Philipose S; Sedej M; Waldhoer M; Peskar BA; Heinemann A
    Pharmacology; 2010; 85(6):372-82. PubMed ID: 20559016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonists of the prostaglandin D2 receptor CRTH2.
    Pettipher R; Hansel TT
    Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
    Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
    Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
    Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
    J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostanoid DP receptor antagonists suppress symptomatic asthma-like manifestation by distinct actions from a glucocorticoid in rats.
    Hirano Y; Shichijo M; Ikeda M; Kitaura M; Tsuchida J; Asanuma F; Yanagimoto T; Furue Y; Imura K; Yasui K; Arimura A
    Eur J Pharmacol; 2011 Sep; 666(1-3):233-41. PubMed ID: 21596028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the potent and selective DP1 receptor antagonist, asapiprant (S-555739), in animal models of allergic rhinitis and allergic asthma.
    Takahashi G; Asanuma F; Suzuki N; Hattori M; Sakamoto S; Kugimiya A; Tomita Y; Kuwajima G; Abraham WM; Deguchi M; Arimura A; Shichijo M
    Eur J Pharmacol; 2015 Oct; 765():15-23. PubMed ID: 26277322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin D2 mediates neuronal protection via the DP1 receptor.
    Liang X; Wu L; Hand T; Andreasson K
    J Neurochem; 2005 Feb; 92(3):477-86. PubMed ID: 15659218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prostaglandin D2, 15-deoxy-Delta12,14-prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats.
    Almishri W; Cossette C; Rokach J; Martin JG; Hamid Q; Powell WS
    J Pharmacol Exp Ther; 2005 Apr; 313(1):64-9. PubMed ID: 15590767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor.
    Shiraishi Y; Asano K; Nakajima T; Oguma T; Suzuki Y; Shiomi T; Sayama K; Niimi K; Wakaki M; Kagyo J; Ikeda E; Hirai H; Yamaguchi K; Ishizaka A
    J Pharmacol Exp Ther; 2005 Mar; 312(3):954-60. PubMed ID: 15528449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of antigen-induced airway inflammation and hyperresponsiveness in guinea pigs by a selective antagonist of "chemoattractant receptor homologous molecule expressed on Th2 cells" (CRTH2).
    Tasaki M; Kobayashi M; Tenda Y; Tsujimoto S; Nakazato S; Numazaki M; Hirano Y; Matsuda H; Terasaka T; Miyao Y; Shimizu Y; Hirayama Y
    Eur J Pharm Sci; 2013 Jun; 49(3):434-40. PubMed ID: 23624353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of MK-7246, a potent and selective CRTH2 (chemoattractant receptor-homologous molecule expressed on T-helper type 2 cells) antagonist.
    Gervais FG; Sawyer N; Stocco R; Hamel M; Krawczyk C; Sillaots S; Denis D; Wong E; Wang Z; Gallant M; Abraham WM; Slipetz D; Crackower MA; O'Neill GP
    Mol Pharmacol; 2011 Jan; 79(1):69-76. PubMed ID: 20943773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the PGD
    Kupczyk M; Kuna P
    Drugs; 2017 Aug; 77(12):1281-1294. PubMed ID: 28612233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of AM211, a potent and selective prostaglandin D2 receptor type 2 antagonist that is active in animal models of allergic inflammation.
    Bain G; Lorrain DS; Stebbins KJ; Broadhead AR; Santini AM; Prodanovich P; Darlington J; King CD; Lee C; Baccei C; Stearns B; Troung Y; Hutchinson JH; Prasit P; Evans JF
    J Pharmacol Exp Ther; 2011 Jul; 338(1):290-301. PubMed ID: 21487069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils.
    Monneret G; Cossette C; Gravel S; Rokach J; Powell WS
    J Pharmacol Exp Ther; 2003 Jan; 304(1):349-55. PubMed ID: 12490611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma.
    Wright CD; Havill AM; Middleton SC; Kashem MA; Lee PA; Dripps DJ; O'Riordan TG; Bevilacqua MP; Abraham WM
    J Pharmacol Exp Ther; 1999 May; 289(2):1007-14. PubMed ID: 10215681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.